ADVANCED BILIARY TRACT CANCER
Clinical trials for ADVANCED BILIARY TRACT CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED BILIARY TRACT CANCER trials appear
Sign up with your email to follow new studies for ADVANCED BILIARY TRACT CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for Tough-to-Treat bile duct cancer
Disease control Recruiting nowThis study is testing a new drug called nanvuranlat for people with advanced bile duct cancer that has worsened after one prior treatment. It will compare nanvuranlat against standard chemotherapy or supportive care to see which helps patients live longer. The trial aims to find …
Matched conditions: ADVANCED BILIARY TRACT CANCER
Phase: PHASE3 • Sponsor: J-Pharma Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New hope for advanced bile duct cancer patients in major trial
Disease control Recruiting nowThis study compares a new three-drug combination (SHR-8068, adebrelimab, and chemotherapy) against the current standard treatment (durvalumab and chemotherapy) for advanced bile duct cancer. It aims to see if the new combination helps patients live longer while monitoring side ef…
Matched conditions: ADVANCED BILIARY TRACT CANCER
Phase: PHASE3 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC